CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HTL Strefa SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HTL Strefa SA
Adamówek 7 Street
Phone: (42) 270-0010p:42 270-0010 Ozorków, 95-035  Poland Fax: (42) 270-0020f:42 270-0020

Business Summary
HTL-STREFA SA is a Poland-based company principally engaged in the manufacture of blood sampling lancets. The Company produces medical equipment, such as: safety lancets for medical professional use to obtain capillary blood samples for various diagnostic purposes, including blood glucose, cholesterol, hemoglobin, C-reactive protein (CRP) tests, blood gas, human immunodeficiency virus (HIV), electrolytes, blood group tests, fungal infection and multiple tests on neonates; personal lancets for self-blood monitoring; and needles. HTL-STREFA SA also runs an independent research and development department. During the fiscal year ended December 31, 2009, the Company a number of subsidiaries, including HTL-STREFA Marketing Sp. z o.o., HT LANCET Sp. z o.o., HTL-STREFA Inc., the United States, HTL-STREFA Gmbh, Germany, Haemedic AB, Sweden and HAEMEDIC Polska Sp. z o.o. The majority shareholder is Terantium Investments Sp. z o.o., holding 97.32% interest.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201012/31/2009Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board HeinoVon Prondzynski 60 12/15/2009 11/15/2009
Chairman of the Management Board, Chief Executive Officer WojciechWyszogrodzki 61 12/15/2009
Vice Chairman of the Supervisory Board AndersWilliamson 12/15/2009 12/11/2009
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Haemedic AB
HTL Strefa S.A.

General Information
Number of Employees: 936 (As of 12/31/2009)
Outstanding Shares: 64,593,731 (As of 3/31/2010)
Stock Exchange: WAR
Fax Number: (42) 270-0020


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023